Monday, May 20, 2013
Ranbaxy Laboratories Ltd.
(NSE:RANBAXY; BSE:500359), Gurgaon, India Business: Generics, Biosimilars
Generics company Ranbaxy pleaded guilty to felony charges relating to the manufacture and distribution of generic drugs made in violation of cGMP practices at its Indian manufacturing facilities in Paonta Sahib and Dewas. In U.S. v. Ranbaxy USA Inc., Ranbaxy pled guilty to three felony counts of